EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Dendritic Cell‐Derived Extracellular Vesicles as Therapeutic Cancer Vaccines: Mechanisms and Optimization Strategies

Jonathan Shpigelman iD, Krishna Rao iD

Immunology · 02.09.2025

DOI: 10.1111/imm.70033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology, online erschienen am 02.09.2025. Verfasst von Jonathan Shpigelman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Southern Illinois University School of Medicine, Springfield, Illinois, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 139 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are ubiquitously secreted nanoparticles that modulate the activities of recipient cells either through the transfer of bioactive cargo or by surface receptor‐mediated signalling. EVs derived from dendritic cells are increasingly recognised as promising platforms for therapeutic cancer vaccines, owing to their immunostimulatory cargo, their capacity to transfer preformed peptide–major histocompatibility complexes to antigen‐presenting cells, and their ability, in some cases, to directly activate cognate T cells. Despite encouraging preclinical results, EV‐based cancer vaccines have demonstrated limited clinical efficacy, constrained by suboptimal immunogenicity, poor lymphoid targeting, and suppression within the tumour microenvironment. Several strategies—including prioritising tumour‐specific neoantigens, co‐administering adjuvants and immunotherapies, optimising EV production and delivery protocols, and engineering EVs with tailored characteristics—aim to overcome these limitations and improve clinical outcomes.

Schlagwörter

Stichwörter der Autor:innen

CD8 cellcancerdendritic cellvaccination

Autor:innen und Institutionen

  • Department of Internal Medicine, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
  • Division of Hematology/Oncology, Simmons Cancer Institute, Springfield, Illinois, USA.

ORCID-Profile: Jonathan Shpigelman, Krishna Rao

Zitieren

APA

Shpigelman, J., & Rao, K. (2025). Dendritic Cell‐Derived Extracellular Vesicles as Therapeutic Cancer Vaccines: Mechanisms and Optimization Strategies. Immunology. https://doi.org/10.1111/imm.70033

Vancouver

Shpigelman J, Rao K. Dendritic Cell‐Derived Extracellular Vesicles as Therapeutic Cancer Vaccines: Mechanisms and Optimization Strategies. Immunology. 2025. doi:10.1111/imm.70033

BibTeX
@article{Shpigelman2025,
  author = {Shpigelman, Jonathan and Rao, Krishna},
  title = {Dendritic Cell‐Derived Extracellular Vesicles as Therapeutic Cancer Vaccines: Mechanisms and Optimization Strategies},
  journal = {Immunology},
  year = {2025},
  doi = {10.1111/imm.70033}
}
Kostenlos starten →